Exact Sciences Corporation Stock Mexican S.E.
Stocks
EXAS *
US30063P1057
Biotechnology & Medical Research
| Market Cap | 20.03B 347B 17.41B 16.2B 14.88B 28.09B 1,912B 28.53B 191B 74.96B 952B 75.21B 73.56B 3,191B | P/E 2024 |
-10.1x | P/E 2025 | -92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.6B 374B 18.77B 17.47B 16.04B 30.3B 2,062B 30.77B 206B 80.84B 1,026B 81.11B 79.32B 3,442B | EV / Sales 2024 |
4.4x | EV / Sales 2025 | 6.42x |
| Free-Float |
98.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Exact Sciences Corporation
| 1 day | -15.23% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.23% | +9.18% | - | - | 20.03B | |
| -22.52% | -18.18% | +95.94% | +79.19% | 3.72B | |
| -6.66% | +1.35% | +118.49% | +183.54% | 3.59B | |
| +14.72% | +17.69% | +257.69% | +288.19% | 2.26B | |
| +3.44% | +4.55% | -27.34% | -35.28% | 2.17B | |
| -13.22% | -18.44% | +51.87% | -43.31% | 1.82B | |
| -2.67% | -2.81% | +195.95% | -45.02% | 969M | |
| +6.96% | -1.82% | -7.40% | +21.17% | 853M | |
| +1.29% | +6.41% | -38.87% | -11.36% | 511M | |
| +7.90% | -3.22% | -0.27% | - | 449M | |
| Average | -2.60% | -2.86% | +71.78% | +54.64% | 1.82B | |
| Weighted average by Cap. | -10.68% | -3.72% | +95.69% | +89.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.76B 47.83B 2.4B 2.23B 2.05B 3.87B 263B 3.93B 26.31B 10.33B 131B 10.36B 10.13B 440B | 3.25B 56.3B 2.82B 2.63B 2.41B 4.56B 310B 4.63B 30.97B 12.15B 154B 12.19B 11.93B 517B |
| Net income | -1.03B -17.84B -894M -832M -764M -1.44B -98.22B -1.47B -9.81B -3.85B -48.9B -3.86B -3.78B -164B | -208M -3.61B -181M -168M -154M -292M -19.85B -296M -1.98B -778M -9.88B -781M -764M -33.14B |
| Net Debt | 1.74B 30.13B 1.51B 1.41B 1.29B 2.44B 166B 2.48B 16.57B 6.5B 82.58B 6.53B 6.38B 277B | 1.57B 27.22B 1.36B 1.27B 1.17B 2.2B 150B 2.24B 14.98B 5.88B 74.62B 5.9B 5.77B 250B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
